EMAIL THIS PAGE TO A FRIEND

Molecular neurodegeneration

Loss of parkin promotes lipid rafts-dependent endocytosis through accumulating caveolin-1: implications for Parkinson's disease.


PMID 26627850

Abstract

Parkinson's disease (PD) is characterized by progressive loss of midbrain dopaminergic neurons, resulting in motor dysfunctions. While most PD is sporadic in nature, a significant subset can be linked to either autosomal dominant or recessive mutations. PARK2, encoding the E3 ubiquitin ligase, parkin, is the most frequently mutated gene in autosomal recessive early onset PD. It has recently been reported that PD-associated gene products such as PINK1, α-synuclein, LRRK2, and DJ-1, as well as parkin associate with lipid rafts, suggesting that the dysfunction of these proteins in lipid rafts may be a causal factor of PD. Therefore here, we examined the relationship between lipid rafts-related proteins and parkin. We identified caveolin-1 (cav-1), which is one of the major constituents of lipid rafts at the plasma membrane, as a substrate of parkin. Loss of parkin function was found to disrupt the ubiquitination and degradation of cav-1, resulting in elevated cav-1 protein level in cells. Moreover, the total cholesterol level and membrane fluidity was altered by parkin deficiency, causing dysregulation of lipid rafts-dependent endocytosis. Further, cell-to-cell transmission of α-synuclein was facilitated by parkin deficiency. Our results demonstrate that alterations in lipid rafts by the loss of parkin via cav-1 may be a causal factor of PD, and cav-1 may be a novel therapeutic target for PD.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2100345
Anti-CAV2 antibody produced in rabbit, affinity isolated antibody
SAB2701001
Anti-CAV2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA044810
Anti-CAV2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
C9992
Anti-Caveolin-2 antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution, western blot: 1 μg/mL
SAB1306490
ANTI-CD71(C-TERMINAL) antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
HPA001396
Anti-FLOT2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4300638
Anti-FLOT2 antibody produced in rabbit, affinity isolated antibody
SAB1405818
Anti-FLOT2, (N-terminal) antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
F1680
Anti-Flotillin 2 (C-terminal) antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
F1805
Anti-Flotillin 2 antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB2502166
Anti-TFRC (N-terminal) antibody produced in goat, affinity isolated antibody, buffered aqueous solution
HPA028598
Anti-TFRC antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4200398
Anti-TFRC antibody produced in rabbit, ~1.0 mg/mL, affinity isolated antibody
SAB1402776
Monoclonal Anti-FLOT2, (N-terminal) antibody produced in mouse, clone 3G6, purified immunoglobulin, buffered aqueous solution